Detailed View
CLYM - Climb Bio, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
486,155,008
Adj EBIT (TTM)
-67,883,000
Enterprise Value
385,075,008
Last Price
7.13
Earnings Yield
-17.63%
Return on Capital
-42.23%
Capital
160,760,000
1Y Price Chart
Last Price: $7.13
1Y Change: 428.15%
As of 2026-03-16 | 1Y Change: 428.15%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -19,296,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -14,892,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -10,677,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -23,018,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -10,911,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -11,732,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -56,372,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -3,005,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.